With our experience of more than 20 years in the sector and the synergy of the global business partnerships we have realized over the years, we are walking towards higher targets in a more determined manner.
With the rare solutions we offer and the services we provide, we are taking decisive and quality steps to become one of the leading rare disease dedicated pharmaceutical companies in Turkey. We increase our competitive power and service efficiency by developing our product portfolio in the best way possible. Thus, we strive to deliver rare disease mediicnes that we assume responsibility for, to patients in the highest quality.
We are moving forward together with you, our valuable business partners, in the mission we have undertaken for the development of medicine and its accessibility to rare treatments. A relationship with our business partners based on scientific and ethical rules is our most basic principle, and in line with this principle, we are investing in the future with our new partners joining our family day by day.
We are progressing in preparation for the challenging conditions that the future will present in the near, medium and long term. We manage our activities with a working understanding that maintains its self-motivation under all conditions and does not compromise its mission and future vision. At this point, we are improving to be with you, our esteemed physicians, and to chart our way with a patient-oriented understanding, with our field staff who are experts in their fields and growing day by day.
While we look to the future with confidence, we promise that we will not compromise on the principles we set when we set out, and that we will always strive for human health.
Caglar Tas
General Manager